Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity

Diabetes

Volumn 64, Issue 4, 2015, Pages 1154-1167

  McCreath, Kenneth J ^a   Espada, Sandra ^a   Gálvez, Beatriz G ^a   Benito, Marina ^a,b   De Molina, Antonio ^a   Sepúlveda, Pilar ^c   Cervera, Ana M ^a,c  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RECEPTOR; SUCCINATE RECEPTOR 1; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GPR91 PROTEIN, MOUSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENERGY EXPENDITURE; FEMALE; GENE DELETION; GENE TARGETING; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN RELEASE; LEAN BODY WEIGHT; LIPID DIET; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; EATING; ENERGY METABOLISM; GENETICS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER; METABOLISM; PANCREAS; PHYSIOLOGY;

ADIPOSE TISSUE, WHITE; ANIMALS; DIET, HIGH-FAT; EATING; ENERGY METABOLISM; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; LIVER; MICE; MICE, KNOCKOUT; OBESITY; PANCREAS; RECEPTORS, G-PROTEIN-COUPLED; TRIGLYCERIDES;

EID: 84929505550     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0346     Document Type: Article

References (50)

1. Flower DR, Attwood TK. Integrative bioinformatics for functional genome annotation: Trawling for G protein-coupled receptors. Semin Cell Dev Biol 2004; 15: 693-701
2. Smith NJ. Low affinity GPCRs for metabolic intermediates: Challenges for pharmacologists. Front Endocrinol (Lausanne) 2012;3: 1
3. Blad CC, Tang C, Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov 2012;11: 603-619
4. Cai TQ, Ren N, Jin L, et al. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochem Biophys Res Commun 2008;377: 987-991
5. Taggart AK, Kero J, Gan X, et al. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005;280: 26649-26652
6. Tokonami N, Morla L, Centeno G, et al. a-Ketoglutarate regulates acid-base balance through an intrarenal paracrine mechanism. J Clin Invest 2013;123: 3166-3171
7. He W, Miao FJ, Lin DC, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004;429: 188-193
8. Krebs HA. Rate control of the tricarboxylic acid cycle. Adv Enzyme Regul 1970;8: 335-353
9. Ashrafian H, Czibik G, Bellahcene M, et al. Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 2012;15: 361-371
10. Hohl C, Oestreich R, Rösen P, Wiesner R, Grieshaber M. Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult rat heart cells. Arch Biochem Biophys 1987;259: 527-535
11. Iles RA, Barnett D, Strunin L, Strunin JM, Simpson BR, Cohen RD. The effect of hypoxia on succinate metabolism in man and the isolated perfused dog liver. Clin Sci 1972;42: 35-45
12. Correa PR, Kruglov EA, Thompson M, Leite MF, Dranoff JA, Nathanson MH. Succinate is a paracrine signal for liver damage. J Hepatol 2007;47: 262-269
13. Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008;14: 1067-1076
14. Aguiar CJ, Andrade VL, Gomes ER, et al. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 2010;47: 37-46
15. Sadagopan N, Li W, Roberds SL, et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens 2007;20: 1209-1215
16. Toma I, Kang JJ, Sipos A, et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008;118: 2526-2534
17. Krebs HA. Chemical composition of blood plasma and serum. Annu Rev Biochem 1950;19: 409-430
18. Nordmann J, Nordmann R. Organic acids in blood and urine. Adv Clin Chem 1961;4: 53-120
19. Ariza AC, Deen PM, Robben JH. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front Endocrinol (Lausanne) 2012;3: 22
20. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149: 1514-1520
21. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002;162: 1867-1872
22. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell 2008;135: 561-571
23. Skarnes WC, Rosen B, West AP, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011;474: 337-342
24. Künnecke B, Verry P, Bénardeau A, von Kienlin M. Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry. Obes Res 2004;12: 1604-1615
25. Corbin IR, Furth EE, Pickup S, Siegelman ES, Delikatny EJ. In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. Biochim Biophys Acta 2009;1791: 757-763
26. Petersen PS, Jin C, Madsen AN, et al. Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism. FASEB J 2011;25: 3803-3814
27. Zhang HH, Huang J, Düvel K, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 2009;4: E6189
28. Sabio G, Kennedy NJ, Cavanagh-Kyros J, et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 2010;30: 106-115
29. Hinke SA, Navedo MF, Ulman A, et al. Anchored phosphatases modulate glucose homeostasis. EMBO J 2012;31: 3991-4004
30. Testa G, Schaft J, van der Hoeven F, et al. A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis 2004;38: 151-158
31. Adham IM, Khulan J, Held T, et al. Fas-associated factor (FAF1) is required for the early cleavage-stages of mouse embryo. Mol Hum Reprod 2008;14: 207-213
32. Galy B, Ferring D, Benesova M, Benes V, Hentze MW. Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo. RNA 2004;10: 1019-1025
33. Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012;15: 279-291
34. Schweiger M, Schreiber R, Haemmerle G, et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006;281: 40236-40241
35. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995;1: 1311-1314
36. Maruhama Y, Ohneda A, Tadaki H, Ohtsuki M, Yanbe A. Hepatic steatosis and the elevated plasma insulin level in patients with endogenous hypertriglyceridemia. Metabolism 1975;24: 653-664
37. Peti-Peterdi J. High glucose and renin release: The role of succinate and GPR91. Kidney Int 2010;78: 1214-1217
38. Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol Rev 2006;86: 435-464
39. Ahmed K, Tunaru S, Tang C, et al. An autocrine lactate loop mediates insulindependent inhibition of lipolysis through GPR81. Cell Metab 2010;11: 311-319
40. Bjursell M, Admyre T, Göransson M, et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 2011;300: E211-E220
41. Jaworski K, Ahmadian M, Duncan RE, et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 2009;15: 159-168
42. Patané G, Caporarello N, Marchetti P, et al. Adiponectin increases glucoseinduced insulin secretion through the activation of lipid oxidation. Acta Diabetol 2013;50: 851-857
43. Xia Z, Stanhope KL, Digitale E, et al. Acylation-stimulating protein (ASP)/ complement C3adesArg deficiency results in increased energy expenditure in mice. J Biol Chem 2004;279: 4051-4057
44. Nogueiras R, López M, Diéguez C. Regulation of lipid metabolism by energy availability: A role for the central nervous system. Obes Rev 2010;11: 185-201
45. Khalifeh-Soltani A, McKleroy W, Sakuma S, et al. Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids. Nat Med 2014;20: 175-183
46. Hu J, Wu Q, Li T, Chen Y, Wang S. Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91. Exp Eye Res 2013;109: 31-39
47. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54: 1615-1625
48. Cummins TD, Holden CR, Sansbury BE, et al. Metabolic remodeling of white adipose tissue in obesity. Am J Physiol Endocrinol Metab 2014;307: E262-E277
49. Elias I, Franckhauser S, Ferré T, et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 2012;61: 1801-1813
50. Regazzetti C, Peraldi P, Grémeaux T, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009;58: 95-103